Multi-Modal Pathology-Radiology Fusion Market Forecast To Reach $3.63 Billion By 2030: Key Growth Drivers And Industry Trends
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Multi-Modal Pathology-Radiology Fusion Market Revenue Growth On Track For A 14.3% CAGR Through 2030
The multi-modal pathology-radiology fusion market has experienced rapid growth in recent years. This market is set to expand from $1.87 billion in 2025 to $2.13 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.1%. Historically, its expansion can be attributed to the rising prevalence of cancer and chronic diseases, the increasing adoption of digital pathology systems, a heightened demand for early and accurate diagnosis, the proliferation of advanced imaging modalities, and growing healthcare digitization initiatives.
The multi-modal pathology-radiology fusion market is projected to experience substantial expansion over the coming years. This market is anticipated to reach $3.63 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.3%. Factors contributing to this growth during the projected period include an escalating need for personalized treatment strategies, enhanced integration of multi-modal diagnostic systems, increased capital expenditure in cloud-based healthcare infrastructure, broader applications within oncology and neurology, and strengthened partnerships between healthcare facilities and research institutions. Key trends foreseen for this period encompass the widespread uptake of integrated diagnostic software, a heightened need for image registration and 3D reconstruction technologies, increased utilization of telepathology and teleradiology solutions, the broadening of workflow integration and clinical decision support functionalities, and a greater emphasis on investing in sophisticated medical imaging hardware.
Get A Free Sample Report With In-Depth Market Insights:
Multi-Modal Pathology-Radiology Fusion Market Growth Backed By Core Demand Fundamentals
The expanding need for individualized healthcare is anticipated to boost the multi-modal pathology-radiology fusion market in the coming years. Personalized medicine refers to a medical approach that tailors healthcare decisions, treatments, and interventions to the individual characteristics of each patient, such as their genetic profile, lifestyle, and environment. This heightened requirement for personalized medicine largely stems from the growing occurrence of chronic and intricate ailments, as bespoke therapies can more efficiently address specific patient requirements and enhance results. Multi-modal pathology-radiology fusion aids personalized medicine by combining cellular-level pathological understanding with extensive imaging information, allowing for accurate disease identification, optimized treatment strategies, and better forecasting of patient-specific responses to therapy. For instance, in February 2024, the FDA gave its approval to 16 novel personalized treatments for patients with rare diseases, an increase from six in 2022, according to the US-based non-profit organization, the Personalized Medicine Coalition. Consequently, the rising demand for personalized medicine is fueling the expansion of the multi-modal pathology-radiology fusion market.
Multi-Modal Pathology-Radiology Fusion Market Segmentation And Category Overview
The multi-modal pathology-radiology fusion market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Modality: Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, X-ray, Digital Pathology, Other Modalities
3) By Deployment Mode: On-Premises, Cloud-Based
4) By Application: Oncology, Neurology, Cardiology, Orthopedics, Other Applications
5) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Other End-Users
Subsegments:
1) By Hardware: Robot Arms and Manipulators, Collaborative Robots (Cobots), End-Effectors and Grippers, Sensors and Perception Hardware, Actuators and Drives, Machine Vision Systems, Controllers and PLCs, Automated Guided Vehicle And Autonomous Mobile Robot, Safety Systems and Fencing, Power and Cabling Infrastructure
2) By Software: Robot Operating Systems and Firmware, Simulation and Digital-Twin Software, Motion Planning and Path Optimization, Artificial Intelligence and Machine Learning Software, Vision and Perception Software, Cell and Fleet Management Software, MES or ERP Integration Software, Predictive Maintenance and Analytics, Cybersecurity Software, Low-Code or No-Code Programming Tools
3) By Services: System Design and Engineering, Integration and Commissioning, Maintenance and Field Support, Training and Skill Development, Retrofit and Modernization Services, Custom Application Development, Robotics-as-a-Service (RaaS), Validation and Testing Services, Consulting and ROI Analysis, R&D and Co-innovation Services
Multi-Modal Pathology-Radiology Fusion Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the multi-modal pathology-radiology fusion market are Google Health LLC, NVIDIA Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., FUJIFILM Healthcare Americas Corporation, IMERIT Inc., Barco N.V., Agfa HealthCare N.V., Tempus AI Inc., Aidoc Medical Ltd., Owkin Inc., Lunit Inc., PAIGE.AI Ltd., Proscia Inc., Canon Medical Systems Corporation, Imagene AI Ltd., Techcyte Inc., Mindpeak GmbH, and Akira AI Inc.
View The Full Multi-Modal Pathology-Radiology Fusion Market Report:
Multi-Modal Pathology-Radiology Fusion Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the multi-modal pathology-radiology fusion market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multi-modal pathology-radiology fusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
